Serum and tissue selenium levels in gastric cancer patients and correlation with CEA

Anticancer Res. 2009 Aug;29(8):3465-7.

Abstract

Background: An inverse relationship between selenium (Se) intake and cancer mortality is evident in humans.

Materials and methods: In eighty patients who had been operated on for primary gastric cancer, serum Se and carcinoembryonic antigen (CEA) levels were measured preoperatively using a fluorometric and immunoradiometric assay (IRMA), respectively.

Results: The serum Se levels were 43+/-6.3 microg l(-1) in the patient group and 68.7+/-4.5 microg l(-1) in healthy individuals (p<0.001). The serum CEA was 12+/-1.9 U ml(-1) in the gastric cancer patients and 2.1 U ml(-1) in the control group (p<0.001). The Se tissue concentrations were 2,640+/-220 mg g(-1) in excised neoplastic tissue and 685+/-115 mg g(-1) in non-neoplastic tissue (p<0.001). An inverse correlation between Se and CEA serum levels was found (r=-0.782). There was no correlation between serum/tissue Se concentration and disease stage/histological type or gender in the patient group.

MeSH terms

  • Adenocarcinoma / metabolism*
  • Adenocarcinoma / secondary
  • Biomarkers, Tumor / blood*
  • Carcinoembryonic Antigen / blood*
  • Case-Control Studies
  • Female
  • Fluorometry
  • Humans
  • Immunoenzyme Techniques
  • Immunoradiometric Assay
  • Intestinal Neoplasms / metabolism*
  • Intestinal Neoplasms / pathology
  • Male
  • Middle Aged
  • Neoplasm Staging
  • Prognosis
  • Selenium / metabolism*
  • Stomach Neoplasms / metabolism*
  • Stomach Neoplasms / pathology

Substances

  • Biomarkers, Tumor
  • Carcinoembryonic Antigen
  • Selenium